- Foster City CA, US Brian A. Carr - Foster City CA, US John Corbin - Oakland CA, US Craig S. Pace - Pacifica CA, US Nathan D. Thomsen - Castro Valley CA, US Xue Zhang - San Diego CA, US
International Classification:
C07K 16/10
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Antibodies That Target Hiv Gp120 And Methods Of Use
- Foster City CA, US Brian A. Carr - Foster City CA, US Magdeleine S. Hung - Mountain View CA, US Manu Kanwar - San Marcos CA, US Craig S. Pace - Belmont CA, US Doug Rehder - Bonsall CA, US Matthew Robert Schenauer - Dana Point CA, US Loredana Serafini - Orinda CA, US Heather Theresa Stephenson - San Jose CA, US Nathan D. Thomsen - Castro Valley CA, US Helen Yu - Mountain View CA, US Xue Zhang - San Diego CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07K 16/10 A61P 31/18
Abstract:
Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Human Immunodeficiency Virus Neutralizing Antibodies
- Foster City CA, US Brian A. Carr - Foster City CA, US John Corbin - Oakland CA, US Craig S. Pace - Belmont CA, US Nathan D. Thomsen - Castro Valley CA, US Xue Zhang - San Diego CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07K 16/10
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Human Immunodeficiency Virus Neutralizing Antibodies
- Foster City CA, US Brian A. Carr - Foster City CA, US John Corbin - Oakland CA, US Craig S. Pace - Belmont CA, US Nathan D. Thomson - Castro Valley CA, US Xue Zhang - San Diego CA, US
International Classification:
C07K 16/10
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
License Records
Xue Sheng Zhang
License #:
78949 - Expired
Category:
Engineers
Issued Date:
Mar 26, 2015
Effective Date:
Mar 14, 2017
Expiration Date:
Feb 28, 2017
Type:
Professional Engineer
Resumes
Independent Individual & Family Services Professional
"We wanted to see whether this problem-solving therapy in particular could modulate the cognitive control circuit," said Xue Zhang, Ph.D., a postdoctoral scholar in psychiatry who is the lead author of the study.